New study on Covid 19 vaccine

 

                    

In studies conducted in a large sample group, it was found that the vaccine developed by Pfizer was 90 percent effective against Kovid-19.

In experiments on tens of thousands of subjects, it was found that the covid-19 vaccine developed by Pfizer and BioNTech prevented the disease by 90 percent.

As we leave eight months behind in the worst pandemic in this century, pioneering results from experiments could allow the company to obtain regulatory approval for emergency use.

The findings are based on an intermediate experiment in which ninety-four participants defeated covid-19. Experiments will continue up to 164 cases. If the data continues to behave like this and the security assessments that Pfizer expected are good, it will be an indication that the world has a new tool to contain the epidemic.

After the news, Pfizer In shares rose around 14 percent in pre-market transactions, while BioNTech warehouse certification rose around 26 percent.